Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0363120120250010025
Korean Journal of Pain
2012 Volume.25 No. 1 p.25 ~ p.32
Efficacy of Glycopyrrolate in Primary Hyperhidrosis Patients
Lee Hyun-Ho

Kim Do-Won
Kim Do-Wan
Kim Chan
Abstract
Background: Primary hyperhidrosis is a disorder of excessive sweating, which shares several features with anxiety disorders and has a negative impact on a patient¡¯s quality of life. Oral glycopyrrolate is one of the treatments available. There are a few published studies on the use of glycopyrrolate given orally in the treatment of hyperhidrosis.

Methods: Thies is study was a review of case notes in a series of 36 patients with primary hyperhidrosis. We made a comparison between the Keller¡¯s scale score of a pre-glycopyrrolate medication group and the Keller¡¯s scale score f a post-glycopyrrolate medication group. The Milanez de Campos score, Short Form_36 (SF-36) score, Beck Depression Inventory (BDI) score, Beck Anxiety Inventory (BAI) score, and autonomic nervous system (ANS) scale score were also compared between the two groups.

Results: In the post-glycopyrrolate medication group, there were declines in Keller¡¯s scale, and Milanez de Campos scale score and BAI score (P £¼ 0.001). In addition, there were increases in SF_36 score in the post-glycopyrrolate medication group (P = 0.03) However, no changes were seen in, BDI score and ANS score in the post-glycopyrrolate medication group (P £¼ 0.001).

Conclusions: Glycopyrrolate is an effective initial method of treating primary hyperhidrosis that, reduces anxiety and improve patients¡¯ quality of life.
KEYWORD
anticholinergic agents, glycopyrrolate, primary hyperhidrosis
FullTexts / Linksout information
 
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø